Bandy Barton P. 4
4 · ReShape Lifesciences Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Bandy Barton P.
DirectorPresident and CEO
Transactions
- Sale
Common Stock, $0.001 par value per share
2022-01-31$1.22/sh−8,324$10,155→ 836,541 total
Footnotes (1)
- [F1]On July 22, 2021, Mr. Bandy was awarded an aggregate of 1,186,006 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units.